[Risk of metastases with a peritoneo-caval shunt for malignant ascites].
D002759:Adenoma, Bile Duct / Q000473:pathology / Q000556:secondary; D000368:Aged; D001650:Bile Duct Neoplasms / Q000473:pathology / Q000556:secondary; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000209:etiology*; D010051:Ovarian Neoplasms / Q000473:pathology; D010534:Peritoneal Neoplasms / Q000473:pathology / Q000556:secondary / Q000601:surgery; D010536:Peritoneovenous Shunt / Q000009:adverse effects*
Zur Frage des Metastasierungs-Risikos bei peritoneocavalem Shunt zur Therapie des malignen Aszites.